Harbour Investments’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.26K | Hold |
60
| – | – | ﹤0.01% | 2785 |
|
|
2025
Q1 | $7K | Buy |
60
+36
| +150% | +$4.2K | ﹤0.01% | 2685 |
|
|
2024
Q4 | $2.03K | Buy |
+24
| New | +$2.03K | ﹤0.01% | 3017 |
|
|
2023
Q4 | – | Sell |
-65
| Closed | -$4.54K | – | 3131 |
|
|
2023
Q3 | $4.54K | Sell |
65
-300
| -82% | -$21K | ﹤0.01% | 2304 |
|
|
2023
Q2 | $26.2K | Buy |
365
+300
| +462% | +$21.6K | ﹤0.01% | 1649 |
|
|
2023
Q1 | $4.01K | Hold |
65
| – | – | ﹤0.01% | 2354 |
|
|
2022
Q4 | $5.01K | Buy |
+65
| New | +$5.01K | ﹤0.01% | 2216 |
|
|
2021
Q4 | – | Sell |
-2
| Closed | – | – | 2695 |
|
|
2021
Q3 | $0 | Hold |
2
| – | – | ﹤0.01% | 3724 |
|
|
2021
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 3758 |
|
|
2021
Q1 | $0 | Buy |
+2
| New | – | ﹤0.01% | 3591 |
|